1.
Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer
OncoLog, Volume 46, Number 02, February 2001
2.
3.
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
4.
5.
6.
7.
Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours
Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.